Clinical factors associated with satisfaction of cancer patients for the treatment of opioid-induced constipation: A post hoc analysis utilizing outcomes of naldemedine phase III study

被引：0
|
作者：
Ishiki, H. [1 ]
Satomi, E. [1 ]
Tada, Y. [2 ]
Yokota, T. [3 ]
Sato, H. [4 ]
Okamoto, M. [5 ]
Osaka, I. [6 ]
机构：
[1] Natl Canc Ctr, Dept Palliat Med, Tokyo, Japan
[2] Shionogi & Co Ltd, Biostat Ctr, Osaka, Japan
[3] Shionogi & Co Ltd, Global Project Management, Osaka, Japan
[4] Shionogi & Co Ltd, Global Med Affairs, Osaka, Japan
[5] Shionogi & Co Ltd, Med Affairs, Osaka, Japan
[6] Shizuoka Canc Ctr, Dept Palliat Med, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
424P
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [21] Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J study): A Post-Hoc Analysis of Lung Cancer Patients
    Imai, H.
    Harada, T.
    Fumita, S.
    Noriyuki, T.
    Gamoh, M.
    Akashi, Y.
    Okamoto, M.
    Kizawa, Y.
    Tokoro, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S872 - S872
  • [22] Post-marketing surveillance of the safety and effectiveness of naldemedine in the management of opioid-induced constipation in patients with cancer pain in Japan
    Takata, Keiko
    Nakazawa, Masami
    Honda, Keiichi
    Hashimoto, Sayo
    SUPPORTIVE CARE IN CANCER, 2022, 30 (05) : 3943 - 3954
  • [23] Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer
    Toshiyuki Harada
    Hisao Imai
    Soichi Fumita
    Toshio Noriyuki
    Makio Gamoh
    Masaharu Okamoto
    Yusaku Akashi
    Yoshiyuki Kizawa
    Akihiro Tokoro
    International Journal of Clinical Oncology, 2021, 26 : 104 - 110
  • [24] Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer
    Harada, Toshiyuki
    Imai, Hisao
    Fumita, Soichi
    Noriyuki, Toshio
    Gamoh, Makio
    Okamoto, Masaharu
    Akashi, Yusaku
    Kizawa, Yoshiyuki
    Tokoro, Akihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) : 104 - 110
  • [25] Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid-induced constipation: A nationwide retrospective cohort study in Japan
    Abe, Hiroaki
    Sumitani, Masahiko
    Matsui, Hiroki
    Inoue, Reo
    Fushimi, Kiyohide
    Uchida, Kanji
    Yasunaga, Hideo
    PHARMACOTHERAPY, 2022, 42 (03): : 241 - 249
  • [26] Post-marketing surveillance of the safety and effectiveness of naldemedine in the management of opioid-induced constipation in patients with cancer pain in Japan Response
    Koczwara, Bogda
    Deckx, Laura
    Ullah, Shahid
    van den Akker, Marjan
    SUPPORTIVE CARE IN CANCER, 2022, 30 (03) : 1897 - 1897
  • [27] Real-World Evidence for the Safety and Effectiveness of Naldemedine in the Management of Opioid-Induced Constipation in Patients With Cancer Pain: Post-hoc Subgroup Analysis of Post-marketing Surveillance in Japan
    Naya, Noriyuki
    Oka, Hiroaki
    Hashimoto, Sayo
    Morioka, Yasuhide
    Kizawa, Yoshiyuki
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [28] Safety and efficacy of naldemedine in cancer patients with opioid-induced constipation: a pooled, subgroup analysis of two randomised controlled studies
    Osaka, Iwao
    Ishiki, Niroto
    Yokota, Takaaki
    Tada, Yukio
    Sato, Hiroki
    Okamoto, Masaharu
    Satomi, Eriko
    ESMO OPEN, 2019, 4 (04)
  • [29] A phase II randomized, double-blind, placebo-controlled study to evaluate naldemedine for the treatment of opioid-induced constipation (OIC) in patients with cancer pain
    Boku, Narikazu
    Katakami, Nobuyuki
    Fujita, Shiro
    Oda, Koji
    Tauchi, Katsunori
    Nakata, Ken
    Shinozaki, Katsunori
    Okuno, Motoyasu
    Kawai, Yasukazu
    Kikukawa, Hiroaki
    Suzuki, Ryujiro
    Nakazawa, Hideo
    Kojima, Hiroshi
    Mizutani, Mitsuhiro
    Hara, Toru
    Yokota, Takaaki
    Suzuki, Yura
    Narabayashi, Masaru
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies
    Camilleri, Michael
    Hale, Martin
    Morlion, Bart
    Tack, Jan
    Webster, Lynn
    Wild, James
    JOURNAL OF PAIN RESEARCH, 2021, 14 : 2179 - 2189
12345